Generic partners India pharma
Wednesday, 27 August, 2008
Biotech Capital [ASX: BTC] investee Generic Health has secured a strategic partnership with one of India's five largest pharmaceutical companies.
Under the arrangement the Indian pharmaceutical company Lupin will become a significant shareholder in Generic Health, obtaining board representation in exchange for a large cash investment.
Lupin will also provide Generic Health with access to 16 dossiers of generic drugs, including 14 already approved by the necessary regulatory bodies, as an in-kind value offer.
Generic Health announced a partnership with Actavis in June this year, and acquired Bellwether Pharma in 2007.
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
'Anti-reward' brain network helps explain cocaine addiction
A new study identifies a specific 'anti-reward' network deep in the brain that undergoes...
